Protara Therapeutics is trading at $4.30 (12.9%) up in pre-market, reversing several days of declines as broader market sentiment improves.
- The jump appears more related to a recovery in risk appetite following the recent market selloff rather than company-specific developments.
- There are currently no fresh earnings reports, regulatory updates, or news items linked to the move.